HLA tapasin independence: broader peptide repertoire and HIV control.
Antigen Presentation
/ genetics
HIV Infections
/ genetics
HIV-1
/ immunology
Histocompatibility Antigens Class I
/ genetics
Human Immunodeficiency Virus Proteins
/ immunology
Humans
Membrane Transport Proteins
/ genetics
Peptides
/ immunology
T-Lymphocytes, Cytotoxic
/ immunology
Viral Load
/ genetics
HLA
peptide repertoire
tapasin
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
10 11 2020
10 11 2020
Historique:
pubmed:
25
10
2020
medline:
5
1
2021
entrez:
24
10
2020
Statut:
ppublish
Résumé
Human leukocyte antigen (HLA) class I allotypes vary in their ability to present peptides in the absence of tapasin, an essential component of the peptide loading complex. We quantified tapasin dependence of all allotypes that are common in European and African Americans (
Identifiants
pubmed: 33097667
pii: 2013554117
doi: 10.1073/pnas.2013554117
pmc: PMC7668082
doi:
Substances chimiques
Histocompatibility Antigens Class I
0
Human Immunodeficiency Virus Proteins
0
Membrane Transport Proteins
0
Peptides
0
tapasin
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
28232-28238Subventions
Organisme : NIAID NIH HHS
ID : R01 AI044115
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI133673
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00001
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400045C
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146240
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068636
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 the Author(s). Published by PNAS.
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
Curr Opin Immunol. 2019 Jun;58:9-15
pubmed: 30771631
FASEB J. 2011 Nov;25(11):3989-98
pubmed: 21836024
Annu Rev Immunol. 2011;29:295-317
pubmed: 21219175
Immunity. 2009 Jan 16;30(1):21-32
pubmed: 19119025
EMBO J. 2007 Mar 21;26(6):1681-90
pubmed: 17332746
Eur J Immunol. 2010 Jan;40(1):214-24
pubmed: 20017190
J Immunol. 2014 Jun 1;192(11):4967-76
pubmed: 24790147
J Exp Med. 2004 Jul 5;200(1):13-24
pubmed: 15226359
Oncoimmunology. 2017 Jan 3;6(2):e1274476
pubmed: 28344889
Sci Rep. 2015 Oct 20;5:14928
pubmed: 26482009
Immunity. 2002 Apr;16(4):509-20
pubmed: 11970875
Nature. 2017 Nov 23;551(7681):525-528
pubmed: 29107940
PLoS Pathog. 2019 Apr 29;15(4):e1007711
pubmed: 31034515
Nat Rev Immunol. 2009 Jul;9(7):503-13
pubmed: 19498380
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5055-5060
pubmed: 30808808
Front Immunol. 2017 Apr 18;8:408
pubmed: 28458665
BMC Bioinformatics. 2005 May 31;6:132
pubmed: 15927070
Eur J Immunol. 1998 Nov;28(11):3783-91
pubmed: 9842921
Mol Biol Evol. 2020 Mar 1;37(3):639-650
pubmed: 31651980
Elife. 2015 Apr 10;4:e05345
pubmed: 25860507
Immunity. 1998 May;8(5):531-42
pubmed: 9620674
J Immunol. 1979 Jul;123(1):342-9
pubmed: 87477
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18220-5
pubmed: 17116884
Nat Microbiol. 2016 Jul;1(7):16068
pubmed: 27375898
Nat Immunol. 2007 Aug;8(8):873-81
pubmed: 17603487
Nat Med. 2007 Jan;13(1):46-53
pubmed: 17173051
J Immunol. 2013 Dec 15;191(12):5831-9
pubmed: 24190657
Science. 1999 Mar 12;283(5408):1748-52
pubmed: 10073943
Nature. 1975 Jul 3;256(5512):50-2
pubmed: 1079575
Science. 2017 Nov 24;358(6366):1060-1064
pubmed: 29025996
Nature. 2010 May 20;465(7296):350-4
pubmed: 20445539
Science. 2016 Feb 12;351(6274):714-20
pubmed: 26797147
J Immunol. 1989 May 1;142(9):3320-8
pubmed: 2785140
Immunogenetics. 2017 Aug;69(8-9):489-498
pubmed: 28695282
J Immunol. 2003 Nov 15;171(10):5264-71
pubmed: 14607927
Annu Rev Immunol. 2013;31:443-73
pubmed: 23298205
Nat Immunol. 2016 Sep;17(9):1067-74
pubmed: 27455421
J Immunol. 2008 Oct 15;181(8):5442-50
pubmed: 18832701
Science. 2017 Nov 24;358(6366):1064-1068
pubmed: 29025991
J Immunol. 2015 Apr 15;194(8):3594-600
pubmed: 25754738
J Immunol. 1994 Dec 15;153(12):5525-36
pubmed: 7989754
Front Immunol. 2018 Apr 27;9:912
pubmed: 29780384
Trends Immunol. 2018 May;39(5):367-379
pubmed: 29396014
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689